FindTrial
Sign In

Clinical study of the application of flurbiprofen axetil in painless artificial abortion

Clinical study of the application of flurbiprofen axetil in painless artificial abortion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15005970
Enrollment
Unknown
Registered
2015-02-12
Start date
2014-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain

Interventions

3 groups:flurbiprofen combined with propofol versus Control

Sponsors

Shandong Provincial Qianfoshan hospital, Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 44 Years

Inclusion criteria

Inclusion criteria: ASA I~II (>18 Years) grade painless artificial abortion patients were selected.

Exclusion criteria

Exclusion criteria: Patients with a history of cardiovascular disease, respiratory system diseases, or allergies to medications as well as patients who used non-steroidal anti-inflammatory drugs before the operation were excluded.

Design outcomes

Primary

MeasureTime frame
BP;HR;SpO2;operating time;postoperative wake time;directional force recovery time;VAS score;VAS score;—

Countries

China

Contacts

Public ContactWei Zhao
spring2003001@126.com+86 18953153216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026